About APCI

APCI logo

Not a member?
Join today!

(800) 532-2724

Since 1984, APCI has been the ‘united voice of independent pharmacy’

APCI began as a small buying group for a limited number of independent pharmacies in central Alabama. Since that time, the cooperative has grown to more than 1,800 members pharmacies in 26 states, and provides its members with a wide range of products and services.

Our mission is to represent the economic and professional interests of independent pharmacies by providing leadership, vision, and a collective voice for our members in the healthcare marketplace. Our goal is to level the playing field for our member pharmacies by providing innovative, targeted programs to benefit our entire membership.

28

Dec

2016

CVS Caremark®: Provider Information Updates - Reminder

Per the 2016 Caremark Provider Manual, unless otherwise specified, Provider must notify Caremark in writing within ten (10) business days of any changes in the documentation and other information provided to Caremark in connection with enrolling as a Provider, including but not limited to, changes in credentialing or quality management initiatives, changes in name, telephone number, fax number, services, or ownership. Provider must notify Caremark in the event of a change in the pharmacy’s physical location, prior to the change.

28

Dec

2016

CVS Caremark®: Management of Select Unapproved Products

Effective January 1st 2017

Effective January 1, 2017, CVS Caremark® will exclude coverage for all new-to-market unapproved products and certain existing unapproved products that may be marketed contrary to the Federal Food, Drug, and Cosmetic Act (FFDCA). Coverage will remain for select unapproved products that are legally marketed1 or deemed clinically necessary (e.g., because no alternatives exist).

*Please see attached PDF for more information.

28

Dec

2016

Argus: Bulletin Communication #44MG16 - 2017 Medicare Opioid Overutilization Edits and POS Override

Effective January 1st 2017

To comply with new regulations from the Centers for Medicaid and Medicare Services (CMS), most Medicare Part D Plans and some commercial plans will be implementing new edits to help manage opioid use within their Medicare populations.

*Please see attached PDF for more information.

28

Dec

2016

OpusHealth: Crown Labs Copay Conversion Program

Effective January 1st 2017

OPUS Health would like to inform you of the following new Copay Assistance Program(s) (see list below). This new program can be viewed on the OPUS Health Pharmacy Portal. Please use the link below to log in and select View New or Modified Programs to view the new program. If you have already created an account, use the email address and password you created to log in. If you do not have an account, please click on the link below and select Create Account to register. Registering takes just a minute or two and provides access to this and all active programs ? even some printable offers you can provide for your pharmacy customers.

28

Dec

2016

Prime Therapeutics: Processing Update for Generic Relpax® for Commercial Covered Persons

Effective December 26th 2016

Dear Valued Provider,

On December 26th, 2016, generic Relpax (eletriptan) will become available to the market. Please see the client specific attachments below for further processing instructions.


If you have any questions about claims processing, please call the Prime Contact Center at 800.821.4795.  

Sincerely,
Pharmacy Network Management
Prime Therapeutics LLC

Prime Therapeutics Contracting Fax number: 877-823-6373

*Please see attached PDF for more information.

First549551Last